T-Cell–Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune Comorbidities-Reference-Cited by-同舟云学术

T-Cell–Specific PTPN2 Deficiency in NOD Mice Accelerates the Development of Type 1 Diabetes and Autoimmune Comorbidities

Published:2019-04-01 Issue:6 Volume:68 Page:1251-1266
ISSN:0012-1797
Container-title:Diabetes
language:en
Short-container-title:Diabetes

Author:

Wiede Florian^ORCID,Brodnicki Thomas C.^ORCID,Goh Pei Kee,Leong Yew A.,Jones Gareth W.,Yu Di,Baxter Alan G.,Jones Simon A.,Kay Thomas W.H.^ORCID,Tiganis Tony^ORCID

Funder

National Health and Medical Research Council

Publisher

American Diabetes Association

Subject

Endocrinology, Diabetes and Metabolism,Internal Medicine

Reference57 articles.

1. Heterogeneity of autoimmune diseases: pathophysiologic insights from genetics and implications for new therapies

2. Robust associations of four new chromosome regions from genome-wide analyses of type 1 diabetes

3. Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls

4. A polymorphism in PTPN2 gene is associated with an earlier onset of type 1 diabetes

5. A Meta-Analysis of Genome-Wide Association Scans Identifies IL18RAP, PTPN2, TAGAP, and PUS10 As Shared Risk Loci for Crohn's Disease and Celiac Disease

Cited by 31 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Therapeutic potential of targeting protein tyrosine phosphatases in liver diseases;Acta Pharmaceutica Sinica B;2024-08

2. Haploinsufficiency in PTPN2 leads to early-onset systemic autoimmunity from Evans syndrome to lupus;Journal of Experimental Medicine;2024-07-19

3. TRAJ23 Gene Targeting as a Therapeutic Strategy for Type 1 Diabetes: Implications from NOD Mouse Model Studies;2024-06-14

4. Immunotherapeutic implications of negative regulation by protein tyrosine phosphatases in T cells: the emerging cases of PTP1B and TCPTP;Frontiers in Medicine;2024-04-19

5. Upregulation of TCPTP in Macrophages Is Involved in IL‐35 Mediated Attenuation of Experimental Colitis;Mediators of Inflammation;2024-01